Uterine leiomyosarcoma is a rare form of cancer. The earlier uterine leiomyosarcoma is diagnosed, the better the outlook. Uterine leiomyosarcoma accounts for 2–5% of all uterine cancers. It starts in ...

Uterine leiomyosarcoma is a rare and aggressive cancer that occurs in the uterus. Individuals usually require a hysterectomy. Treatments can also include chemotherapy or radiotherapy. Leiomyosarcoma ...

Leiomyosarcomas are cancers that develop in a type of muscle tissue called smooth muscle. These muscles are found in the walls of muscular organs like the heart and the stomach. They are rare and ...

Leiomyosarcoma is one of the most common sarcoma subtypes. It is a cancer that grows in smooth muscle cells, meaning it can develop anywhere in the body. There are often great differences between ...

Editor's Note: Uterine leiomyosarcomas are aggressive, heterogeneous cancers associated with high rates of progression and recurrence—and poor outcome. Uterine sarcomas as a group are uncommon cancers ...

DelveInsight’s, “Leiomyosarcoma Pipeline Insight” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Leiomyosarcoma pipeline landscape. It covers the Leiomyosarcoma ...

Luveltamab tazevibulin, a novel ADC, showed encouraging responses in platinum-resistant ovarian cancer, with a 32% ORR and a ...

In 2002, the then 24-year-old revealed that she had been diagnosed with the rare form of cancer while pregnant with her son Harvey, 23. Katie, 47, was told that she had leiomyosarcoma or LMS, which ...